Objective estimates of the probability of developing hypothyroidism following radioactive iodine treatment of thyrotoxicosis

European Journal of Endocrinology

Volumn 146, Issue 6, 2002, Pages 767-775

  Ahmad, Aftab M ^a   Ahmad, Munir ^a   Young, Eric T ^a  

^a WANSBECK GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; LIOTHYRONINE; RADIOACTIVE IODINE; THYROID ANTIBODY; THYROID HORMONE; THYROTROPIN; THYROXINE;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG MEGADOSE; EUTHYROIDISM; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL RECORD; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; RISK FACTOR; SUBSTITUTION THERAPY; THYROID NODULE; THYROTOXICOSIS; TOXIC GOITER; TREATMENT OUTCOME;

EID: 0036299628     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1460767     Document Type: Article

References (31)

1. Intentional radio-iodine ablation in Graves' disease
2. 131I therapy for Graves' disease
3. Long-term results from graded low dose radioactive iodine therapy for thyrotoxicosis
4. 131I-therapy of hyperthyroidism ablative?
5. Ablative radioiodine therapy for hyperthyroidism: Long term follow up study
6. Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while?
7. Long-term follow-up of treatment of thyrotoxicosis by three different methods
8. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: A population-based cohort study
9. 131I therapy for hyperthyroidism in relation to immunologic parameters
10. 131I treatment protocols for Graves' disease
11. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism
12. Thionamides alter the efficacy of radioiodine treatment in patients with Graves' disease
13. Success rate of radioiodine therapy in Graves' disease: The influence of thyrostatic medication
14. Treatment of hyperthyroidism with sodium iodide I-131. A 16-year experience
15. A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves' hyperthyroidism
16. Age and gender predict the outcome of treatment for Graves' hyperthyroidism
17. Relation between several variables
18. 131I
19. The utilization of small repeated doses of iodine 131 in the treatment of Graves' disease. Results
20. Radioiodine treatment of hyperthyroidism - Prognostic factors for outcome
21. Diagnosis and management of large toxic multinodular goiters
22. Iodine-131 treatment of hyperthyroidism: Current issues
23. Antithyroid drugs and radioactive iodine. Fifteen years' experience with Graves' disease
24. Simultaneous treatment of toxic diffuse goiter with I-131 and antithyroid drugs: A prospective study
25. Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease
26. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease
27. 131I therapy: The small pool syndrome
28. Effect of antithyroid therapy on the long-acting thyroid stimulator and antithyroglobulin antibodies
29. Humoral and genetic aspects of thyroid autoimmunity
30. 131I therapy for Graves' disease
31. The evaluation of radioiodine therapy for thyroid patients using a fixed-dose regime